Cargando…

Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson’s Disease

Ceramides are a family of bioactive lipids belonging to the class of sphingolipids. Sphingolipidoses are a group of inherited genetic diseases characterized by the unmetabolized sphingolipids and the consequent reduction of ceramide pool in lysosomes. Sphingolipidoses include several disorders as Sa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paciotti, Silvia, Albi, Elisabetta, Parnetti, Lucilla, Beccari, Tommaso
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073989/ https://www.ncbi.nlm.nih.gov/pubmed/32098196 http://dx.doi.org/10.3390/jcm9020594

Ejemplares similares

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
por: Sjödin, Simon, et al.
Publicado: (2019)

Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease
por: Parnetti, Lucilla, et al.
Publicado: (2014)

Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies
por: Moors, Tim E., et al.
Publicado: (2018)

Factors Influencing the Measurement of Lysosomal Enzymes Activity in Human Cerebrospinal Fluid
por: Persichetti, Emanuele, et al.
Publicado: (2014)

Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
por: Chiasserini, Davide, et al.
Publicado: (2015)

Microglia and Brain Disorders: The Role of Vitamin D and Its Receptor
por: Mirarchi, Alessandra, et al.
Publicado: (2023)

Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
por: Moors, Tim E., et al.
Publicado: (2017)

Vitamin D3 Enriches Ceramide Content in Exosomes Released by Embryonic Hippocampal Cells
por: Conte, Carmela, et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson’s disease: protocol for a systematic review and individual participant data meta-analysis
por: Eusebi, Paolo, et al.
Publicado: (2017)

Ceramide Metabolism and Parkinson’s Disease—Therapeutic Targets
por: Custodia, Antía, et al.
Publicado: (2021)

Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of “Protein-Misfolding Cyclic Amplification” and “Real-Time Quaking-Induced Conversion” as Diagnostic Tools
por: Paciotti, Silvia, et al.
Publicado: (2018)

The Challenge of Disease-Modifying Therapies in Parkinson’s Disease: Role of CSF Biomarkers
por: Paolini Paoletti, Federico, et al.
Publicado: (2020)

Ceramide releases exosomes with a specific miRNA signature for cell differentiation
por: Fiorani, Federico, et al.
Publicado: (2023)

Inhibition of Ceramide Synthesis Reduces α-Synuclein Proteinopathy in a Cellular Model of Parkinson’s Disease
por: Mingione, Alessandra, et al.
Publicado: (2021)

Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?
por: Bellomo, Giovanni, et al.
Publicado: (2020)

The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer’s Disease, Parkinson’s Disease and Multiple Sclerosis
por: Paolini Paoletti, Federico, et al.
Publicado: (2021)

Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson’s Disease
por: Blumenreich, Shani, et al.
Publicado: (2020)

Possible Stress–Neuroendocrine System–Psychological Symptoms Relationship in Pregnant Women during the COVID-19 Pandemic
por: Gizzi, Giulia, et al.
Publicado: (2022)

Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer’s Disease: ELISA Development and Clinical Validation
por: Wojdała, Anna Lidia, et al.
Publicado: (2022)

The Multiple Roles of Sphingomyelin in Parkinson’s Disease
por: Signorelli, Paola, et al.
Publicado: (2021)

Role of Ceramides and Lysosomes in Extracellular Vesicle Biogenesis, Cargo Sorting and Release
por: Horbay, Rostyslav, et al.
Publicado: (2022)

Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer’s disease continuum
por: Paciotti, Silvia, et al.
Publicado: (2023)

Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers
por: Farotti, Lucia, et al.
Publicado: (2020)

The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients
por: Nuzzo, Tommaso, et al.
Publicado: (2019)

Spaceflight Induced Disorders: Potential Nutritional Countermeasures
por: Costa, Fabio, et al.
Publicado: (2021)

Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer’s Disease and Other Neurological Disorders
por: Bellomo, Giovanni, et al.
Publicado: (2021)

Implication of Ceramide, Ceramide 1-Phosphate and Sphingosine 1-Phosphate in Tumorigenesis
por: Gangoiti, Patricia, et al.
Publicado: (2008)

The Emerging Role of the Lysosome in Parkinson’s Disease
por: Navarro-Romero, Alba, et al.
Publicado: (2020)

Visualization of ceramide channels in lysosomes following endogenous palmitoyl-ceramide accumulation as an initial step in the induction of necrosis
por: Yamane, Mototeru, et al.
Publicado: (2017)

Ceramide and ceramide 1-phosphate in health and disease
por: Arana, Lide, et al.
Publicado: (2010)

Radiation and Thyroid Cancer
por: Albi, Elisabetta, et al.
Publicado: (2017)

e-Cadherin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson Disease
por: Cataldi, Samuela, et al.
Publicado: (2016)

Alpha-Mannosidosis: Therapeutic Strategies
por: Ceccarini, Maria Rachele, et al.
Publicado: (2018)

Contribution of specific ceramides to obesity-associated metabolic diseases
por: Hammerschmidt, Philipp, et al.
Publicado: (2022)

Potential Drug Targets for Ceramide Metabolism in Cardiovascular Disease
por: Guo, Jiaying, et al.
Publicado: (2022)

The Impact of Phytochemicals in Obesity-Related Metabolic Diseases: Focus on Ceramide Metabolism
por: Kim, Eunkyeong, et al.
Publicado: (2023)

Gentamicin Arrests Cancer Cell Growth: The Intriguing Involvement of Nuclear Sphingomyelin Metabolism
por: Codini, Michela, et al.
Publicado: (2015)

Role of hypothalamic de novo ceramides synthesis in obesity and associated metabolic disorders
por: Magnan, Christophe, et al.
Publicado: (2021)

Risk factors of levodopa-induced dyskinesia in Parkinson’s disease: results from the PPMI cohort
por: Eusebi, Paolo, et al.
Publicado: (2018)

Lysosomal function in macromolecular homeostasis and bioenergetics in Parkinson's disease
por: Schneider, Lonnie, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_lqu9qm13v3aevif5epnqhoioil